Profil
Jennifer Zibuda worked as a Director of Investor Relations & Communications at Prothena Corp.
Plc from 2020 to 2023.
Prior to that, she worked as an Investor Relations Contact at Portola Pharmaceuticals, Inc. and as the Head of Corporate Communications at Alkermes Plc.
Anciens postes connus de Jennifer Zibuda
| Sociétés | Poste | Fin |
|---|---|---|
| PROTHENA CORPORATION PLC | Investor Relations Contact | 01/01/2023 |
| ALKERMES PLC | Public Communications Contact | 01/06/2018 |
| PORTOLA PHARMACEUTICALS, INC. | Investor Relations Contact | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PROTHENA CORPORATION PLC | Health Technology |
| ALKERMES PLC | Health Technology |
| Entreprise privées | 1 |
|---|---|
Portola Pharmaceuticals LLC
 Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Portola Pharmaceuticals, Inc. engaged in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA. | Health Technology |
